Franklin Resources’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Franklin Resources’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-399,714	Closed	-$1.36M	–	1554
2017 Q1	$1.36M	Hold	399,714	–	–	﹤0.01%	1291
2016 Q4	$2.08M	Hold	399,714	–	–	﹤0.01%	1226
2016 Q3	$10.1M	Hold	399,714	–	–	0.01%	977
2016 Q2	$9.88M	Hold	399,714	–	–	0.01%	969
2016 Q1	$11.6M	Buy	399,714 +59,962	+18%	+$1.63M	0.01%	939
2015 Q4	$12.6M	Buy	339,752 +20,438	+6%	+$902K	0.01%	958
2015 Q3	$15.6M	Buy	319,314 +30,875	+11%	+$2.16M	0.01%	914
2015 Q2	$19.9M	Hold	288,439	–	–	0.01%	891
2015 Q1	$10.3M	Buy	288,439 +118,712	+70%	+$3.51M	﹤0.01%	1045
2014 Q4	$2.15M	Buy	169,727 +49,238	+41%	+$715K	﹤0.01%	1302
2014 Q3	$1.85M	Hold	120,489	–	–	﹤0.01%	1321
2014 Q2	$3.27M	Buy	120,489 +19,137	+19%	+$472K	﹤0.01%	1245
2014 Q1	$2.72M	Hold	101,352	–	–	﹤0.01%	1243
2013 Q4	$2.49M	Buy	101,352 +14,388	+17%	+$371K	﹤0.01%	1237
2013 Q3	$2.8M	Buy	86,964 +32,537	+60%	+$1.01M	﹤0.01%	1191
2013 Q2	$1.61M	Buy	+54,427	New	+$2.03M	﹤0.01%	1229

Other funds holding ANTH

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Franklin Resources's ANTH Position: Q2 2017 in Review

Franklin Resources sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 399,714 shares — an estimated $1.36M sold.

Franklin Resources first reported a position in ANTH in Q2 2013 and held it in 16 quarters. The position peaked at $19.9M in Q2 2015. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

Franklin Resources reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Franklin Resources sold 399,714 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $1.36M.
Franklin Resources first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
Franklin Resources's Anthera Pharmaceuticals, Inc. position peaked at $19.9M in Q2 2015.
40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on Franklin Resources's 13F filing for Q2 2017, filed 10 Aug 2017.